[Resumption of Enfortumab Vedotin Supported by Diagnosis of a Late- Onset Immune-Related Adverse Event in Metastatic Urothelial Carcinoma : A Case Report].

Takeru Fujimoto,Yoshio Sugino, Kazuma Soya, Kana Kohashiguchi, Sachiko Higashino, Fumihiro Uwamori, Yusuke Takei,Hiroshi Iwamura

Hinyokika kiyo Acta urologica Japonica（2024）

Cited 0|Views0

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined